VOYA Investment Management’s Cardiff Oncology CRDF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19K Sell
11,752
-810
-6% -$1.66K ﹤0.01% 2334
2025
Q4
$35.3K Hold
12,562
﹤0.01% 2369
2025
Q3
$25.9K Sell
12,562
-5,323
-30% -$14.7K ﹤0.01% 2430
2025
Q2
$56.3K Buy
17,885
+1,781
+11% +$5.43K ﹤0.01% 2581
2025
Q1
$50.6K Buy
16,104
+2,980
+23% +$11.8K ﹤0.01% 2548
2024
Q4
$57K Buy
+13,124
New +$41K ﹤0.01% 2663
2022
Q2
Sell
-14,452
Closed -$36K 2793
2022
Q1
$36K Hold
14,452
﹤0.01% 2616
2021
Q4
$87K Sell
14,452
-20
-0.1% -$119 ﹤0.01% 2681
2021
Q3
$96K Hold
14,472
﹤0.01% 2744
2021
Q2
$96K Buy
+14,472
New +$123K ﹤0.01% 2777
2017
Q2
Sell
-182
Closed -$15K 2640
2017
Q1
$15K Hold
182
﹤0.01% 2505
2016
Q4
$28K Hold
182
﹤0.01% 2519
2016
Q3
$59 Hold
182
﹤0.01% 2523
2016
Q2
$59K Hold
182
﹤0.01% 2538
2016
Q1
$61K Hold
182
﹤0.01% 2464
2015
Q4
$71K Hold
182
﹤0.01% 2519
2015
Q3
$75K Hold
182
﹤0.01% 2527
2015
Q2
$133K Buy
+182
New +$129K ﹤0.01% 2589

Other funds holding CRDF

VOYA Investment Management's CRDF Position: Q1 2026 in Review

VOYA Investment Management reduced its Cardiff Oncology (CRDF) stake by 6.4% in Q1 2026, selling an estimated $1.66K and leaving 11,752 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #2334.

VOYA Investment Management first reported a position in CRDF in Q2 2015 and has held it in 18 quarters since. The position peaked at $133K in Q2 2015. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • VOYA Investment Management held 11,752 shares of Cardiff Oncology worth $19K as of Q1 2026.
  • VOYA Investment Management sold 810 Cardiff Oncology shares in Q1 2026, an estimated $1.66K.
  • Cardiff Oncology made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #2334 holding.
  • VOYA Investment Management first reported a position in Cardiff Oncology in Q2 2015 and has held it in 18 quarters since.
  • VOYA Investment Management's Cardiff Oncology position peaked at $133K in Q2 2015.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.